Match Document Document Title
DE102007015775A1 A method for detecting Paratuberkolose  
The This invention relates to a method for specifically and sensitive detection of Mycobacterium avium ssp. paratuberculosis (MAP). In fecal, tissue and organ samples using a real-time PCR methods
DE102006050091A1 Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients  
The This invention relates to novel processes for the selective localization of active ingredients both at and in mitochondria within living cells and agents that through without further aids...
DE102007010252B4 Control genes for normalization of gene expression analysis data  
Control gene set for the normalization of gene expression analysis data from blood samples of patients with diseases with systemic immune response, especially SIRS, sepsis, severe sepsis, septic...
DE102007010252A1 Set of control genes for normalizing gene expression data from blood samples comprises seven RNA sequences  
Set of control genes for normalizing gene expression data from blood samples comprises seven RNA sequences corresponding to GenBank accession numbers NM001562, NM001228, NM001993, NM002209,...
DE102007010311A1 Organism-specific hybridizable nucleic acid molecule  
The This invention relates to a method for producing a organism-specific hybridizable nucleic acid molecule, a product made by this method nucleic acid molecule, a kit which comprises at least one...
DE102007009073A1 Crosslinked poly(meth)acrylic acid cation exchanger, e.g. for water treatment, is obtained by polymerizing pearl-form monomer drops while supplying monomers, crosslinker and optionally initiator  
Production of crosslinked poly(meth)acrylic acid type cation exchangers (I) involves polymerizing pearl-form monomer drops in a (preferably aqueous) continuous phase, while supplying a mixture of...
DE102007007644A1 New aminocoumarin compounds, designated novclobiocins, useful as broad-spectrum antibiotics and cytotoxic agents, prepared sing genetically modified bacterial strains  
New aminocoumarin compounds (I), designated novclobiocins, consist of clorobiocin analogs containing modified N-acyl residues and/or 8-substituents. Aminocoumarin compounds of formula (I) are new....
DE102007007738A1 Color-coded oligosaccharides or polysaccharides  
The Invention relates to color-marked oligosaccharides or polysaccharides, process for producing these color-marked oligosaccharides or polysaccharides and their use for kidney function determination.
DE102007005804A1 Secreted luciferase Lu164M3 and their use  
The Invention relates to the nucleotide and amino acid sequence and the type and use of Lu164M3 and the Use of secreted luciferases.
DE102007005803A1 Secreted luciferase MLuc7 and their use  
The Invention relates to the nucleotide and amino acid sequence and the type and use of the secreted luciferase MLuc7.
DE102007005655A1 Apparatus and method for purification of nucleic acids  
disclosed A device for purification of nucleic acids by negative chromatography comprising a hollow body each having an opening at the upper and at the lower end, which includes a stationary solid...
DE102007027201A1 Conjugates useful for chemotherapy or positron emission tomography comprising a platinum complex and a glucose compound  
Conjugates comprising a chemotherapy-active platinum complex and a glucose compound, optionally linked together via a spacer, are new. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF...
DE102007002386A1 Pharmaceutically active compounds  
The present invention relates to pharmaceutically active compounds from an isoflavone or isoflavone glycoside and covalently with this connected, an amino acid, a peptide or peptide derivative...
DE10085149B4 A process for preparing acarbose with high purity  
process for producing highly pure acarbose with an acarbose content of at least 98%, comprising the steps of: Filtering a acarbose containing fermentation culture, Adjusting the pH of the Filtrate...
DE102006059095A1 Microarray for detecting viruses is divided into fields, each bearing a nucleic acid probe capable of detecting a specific herpes virus  
Microarray for detecting viruses is divided into fields, each bearing a nucleic acid probe capable of detecting a specific virus, namely a herpes simplex virus probe, a varicella zoster virus...
DE102006054233A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE102006054213A1 Homogeneous phase acetalation of oligo- or polysaccharide, e.g. for production of acid-crosslinkable cellulose acetals, by reaction with vinyl ether in solution in ionic liquid  
Acetalation of di-, oligo- or polysaccharides (or their derivatives) (I) is carried out by dissolving (I) in at least one ionic liquid (II) and reacting with a vinyl ether (III). Independent...
DE102006054202A1 Alleles of oxyR gene from corynebacteria  
The Invention relates to mutants and alleles of the gene of coryneform oxyR Bacteria coding for Variants of the OxyR-transcriptional regulator, and methods for preparing of amino acids by using...
DE102007045173A1 Nucleotide analogs useful for nucleic acid synthesis or sequencing comprise a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker  
Nucleotide analogs (I) comprising a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker are new. Independent claims are also included for: (1) nucleic acid...
DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer  
Anionic cyclopentadienyl-carbohydrate compounds (I), are new. Anionic cyclopentadienyl-carbohydrate compounds of formula (I), are new. m : 0-10 (preferably 1); ER1 : OH, alkoxy, nucleo-base or...
DE102006053637B4 Last fluoro-substituted 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of the formula I, which mean X NH; R1 (C1-C6) Alkyl; R4 F; R4 'H, F; R2, R2 ', R3, R3', R5, R5 'independently of one another H, F, Cl, Br, I, OH, - (CH2) -OH, CH2F, CHF2, CF3, NO2, N3,...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053635B4 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of formula and the pharmaceutically acceptable salts thereof.
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102006053385B4 Enterococcus faecalis antigen  
Enterococcus faecalis strain type 5 antigen, at least one disaccharide unit comprising, having the following formula: where R1 OH, X = O, Y = O and CA lactyl is.
DE102006053385A1 Enterococcus faecalis and / or Enterococcus faecium antigen  
The This invention relates generally to the field of detection and prevention of infectious diseases caused by Enterococcus faecalis and / or Enterococcus faecium caused. In particular relates to...
DE102006035393A1 Prognostic markers for the classification of the three-year progessionsfreien survival of patients with colon cancer based on expression profiles of biological samples  
The Invention relates to the use of gene expression profiles for Predicting the three-year progression-free survival or recurrence of patients receiving colorectal cancer in UICC stage I or II was...
DE202005021489U1 A composition as for the synthesis of compounds phosphitylated  
Composition, containing a compound capable of forming enolates, and a phosphoramidite.
DE202005021488U1 Mixture of an activator and an additive for preparing phosphitylated compounds  
A Mixture of an activator having the formula I wherein R = alkyl, cycloalkyl, Aryl, aralkyl, heteroalkyl, heteroaryl R1. R2 = Either hydrogen or together form a 5- or 6-membered ring X1, X2 =...
DE112004002408B4 A process for obtaining an enriched population of siRNA-expressing cells  
process for obtaining cells which are capable of inhibiting RNA expressing, said method comprising: introducing at least one nucleic acid in a cell, wherein the at least one nucleic acid in the...
DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues  
New metal chelates (I) (optionally in salt form) contain (a) perfluorinated polyethylene glycol (PEG) residue(s), (b) chelator residue(s) and (c) at least one equivalent of metal(s) of atomic...
DE102007016151A1 coated implant  
implant with a coating, wherein the implant is an amino-functionalized Parylene, an oligonucleotide and / or an oligopeptide comprising, which have a specific binding affinity for CD 34-positive...
DE102006042891A1 Breaking down of poly-, oligo-, disaccharide or its derivatives, useful as raw material e.g. in textile industry, comprises dissolving the derivatives in an ionic liquid and treating the mixture at an elevated temperature  
Method for breaking down of poly-, oligo-, disaccharide (I) or its derivative comprises dissolving (I) in an ionic liquid and treating the mixture at an elevated temperature, optionally in the...
DE102006042890A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE102006037786A1 Nucleosides, containing these drugs and their use  
The Invention relates to specific nucleosides, and drugs which these nucleosides contained. Furthermore, the invention relates to the Use of such nucleosides for the preparation of a medicament,...
DE102006039479A1 Programmable oligonucleotide  
The Invention relates to methods and apparatus for the preparation of synthetic nucleic acids.
DE102007007750A1 avermectin  
New Avermectin derivatives of the formula (I), in which -C22R1-AC23R2. R3, R4 and R5 the meanings indicated in the description have,Methods for preparing these substances and their use for...
DE102006037580A1 Sandel Perfume receptors  
The Invention relates to the field of olfactory receptors, the receptive influencing Medications and biosensors. The invention further relates to compounds of the general formula (I), in whichX...
DE102006037581A1 Citrusal Perfume receptors  
The Invention relates to the field of olfactory receptors, the empfängsnisbeeinflussenden Medications and biosensors.
DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria  
Nucleic acid (I) is new. Nucleic acid of formula G lX mG n (I) is new. G = guanosine, uracil or an analog; X = guanosine, uracil, adenosine, thymidine, cytosine or an analog; l = 1-40; m >= 3; and...
DE102006032569A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE69133552C5 Deoxyribonucleic acid sequence encoding non-A, non-B hepatitis virus - obtd. Hutch C59 subgroup encoding polypeptide(s), useful as vaccines, and immuno reactive ABS for diagnosis of virus  
Sequence (I) comprises (a) the Hutch c59 DNA sequence shown in SEQ ID NO:46 of the spec; (b) degenerate sequences of the sequence of (a); (c) a mutant variant of the NANBV Hutch c59 strain with...
DE3890998B4 Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it  
Neutrophilenaktivierungsfaktor (NAF) which is derived from human monocytes and the following amino acid sequence comprising:...
DE102006029306A1 Silylation of polysaccharide, especially cellulose, to give products for use in the textiles, food, building and paint industries, involves dissolving in ionic liquid and reacting with a silylating agent  
A method for the silylation of poly-, oligo- or di-saccharides or their derivatives involves dissolving these compounds in ionic liquid(s) and reacting them with a silylating agent.
DE102006028165A1 A process for the acylation of cellulose  
The This invention describes a method for the acylation of Poly-, oligo- or disaccharides or derivatives thereof, by this in an ionic liquid triggers and reacted with a ketene, and new acylated...
DE102006025154A1 Mutated DNA polymerase with increased reverse transcriptase activity  
The This invention relates to a DNA polymerase with increased reverse Transcriptase activity, which compared to the wild-type variant at least one mutation in their amino acid sequence comprises,...
DE102006025153A1 Mutant DNA polymerases with higher selectivity  
The This invention relates to a DNA polymerase with increased mismatch discrimination, which compared to the wild-type variant at least one mutation in their amino acid sequence comprises, as well...
DE102006022569B4 Spezies-unabhängiges Nachweisverfahren für biologisches Material  
Verwendung mindestens eines ersten Primers zur DNA-Fingerprint-Analyse, wobei der mindestens erste Primer eine Sequenz enthält, die von einer 8 bp langen palindromischen oder GC-reichen Sequenz...
DE102006020885A1 Inserting a tag sequence into a nucleic acid comprises using an anchor oligonucleotide comprising a hybridizing anchor sequence and a nonhybridizing tag-template sequence  
Inserting a tag sequence into a nucleic acid comprises hybridizing an anchor sequence of an anchor oligonucleotide to a sequence segment of a template nucleic acid and synthesizing a new nucleic...
DE102006019480A1 Use of gene expression profiles to detect any postoperative tissue incompatibility reactions after liver transplantation  
Gene expression profiles obtained from a patient sample in vitro are used to detect any postoperative tissue incompatibility reactions after liver transplantation. An independent claim is also...